Exagen Inc. XGN Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 58.3%-1.2pp | 59.5%+3.5pp | 56.1%+9.2pp | 46.9%-10.5pp | |
| Operating margin | -21.1%+3.4pp | -24.5%+19.0pp | -43.5%+57.6pp | -101.1%-51.2pp | |
| Net margin | -30%-2.8pp | -27.2%+17.9pp | -45.1%+58.9pp | -104%-48.4pp | |
| Returns | |||||
| Return on equity | -147.8%-54.1pp | -93.8%-21.1pp | -72.7%+1.7pp | -74.4%-32.0pp | |
| Return on invested capital | -120.5%+11.0pp | -131.5%+44.2pp | -175.7%+131pp | -306.8%-132pp | |
| Efficiency | |||||
| Asset turnover | 1.3×+0.2× | 1.1×+0.4× | 0.7×+0.3× | 0.4×0.0× | |
| Liquidity | |||||
| Current ratio | 3.5×+0.8× | 2.7×-1.3× | 4×-3.5× | 7.5×-4.6× | |
| Leverage | |||||
| Debt-to-equity | 1.6×-0.9× | 2.4×+1.4× | 1.1×+0.2× | 0.8×+0.5× | |
| Per Share | |||||
| Book value per share | $0.81+54.4% | $0.52-59.2% | $1.28-48.4% | $2.49-53.3% | |
| Valuation | |||||
| Market capitalization | $112.34M-26.5% | $72.31M+104% | $35.49M-9.4% | $39.17M-79.2% | |
| Price / sales | 1.6×-1.0× | 1.3×+0.6× | 0.7×-0.2× | 0.9×-3.0× | |
| Price / book | 7.8×+0.5× | 7.6×+6.0× | 1.6×+0.6× | 0.9×-1.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Exagen Inc.'s profit margins?
- Exagen Inc. (XGN) runs a 58.3% gross margin and a -20.6% operating margin, with a -29.5% net margin.
- Where do Exagen Inc.'s ratios come from?
- Every ratio is computed from Exagen Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
